youtube_live
Q3 2026 earnings • released • Revenue beat +35.39%
See resultschevron_right
SDGR:NASDAQ
Schrodinger Inc
$28.77
arrow_upward
+0.88%(+0.25) 1D
$28.57
arrow_downward
-0.70% (-0.20)todayPre-market
Closed: Nov 5, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDGR...
Open
$29.10
High
$30.09
Low
$27.16
Mkt. cap
2.15B
Avg. vol.
2.32M
Volume
7.48K
52-wk high
$33.78
52-wk low
$10.95
EPS
-$0.74
Beta
1.69
Shares outstanding
65.64M
No. of employees
850
Open
$29.10
High
$30.09
Low
$27.16
Mkt. cap
2.15B
Avg. vol.
2.32M
Volume
7.48K
52-wk high
$33.78
52-wk low
$10.95
EPS
-$0.74
Beta
1.69
Shares outstanding
65.64M
No. of employees
850
News stories
From web sources and news partners
Securities.io
·
1 day ago
Schrödinger Raises 2026 Outlook as Q3 Revenue Grows 19%
Benzinga
·
1 day ago
Schrodinger Q3 2026 Earnings Call Transcript
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc